Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
EDIT
Editas Medicine
Last Price:
$1.33
Seasonality Move:
-11.28%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.54 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 2.6 | Sell |
200-day SMA: | 4.58 | Sell |
8-day EMA: | 1.53 | Sell |
20-day EMA: | 1.88 | Sell |
50-day EMA: | 2.47 | Sell |
200-day EMA: | 4.44 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 23.89 | Sell |
Chaikin Money Flow: | -1676224 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.63 - 2.43) | Sell |
Bollinger Bands (100): | (2.37 - 4.05) | Sell |
Editas Medicine Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.31 while EDIT 8-day simple moving average is 1.54, which is a Sell signal.
-
The stock price of EDIT is 1.31 while Editas Medicine 20-day SMA is 1.92, which makes it a Sell.
-
Editas Medicine 50-day simple moving average is 2.60 while EDIT share price is 1.31, making it a Sell technically.
-
EDIT stock price is 1.31 and Editas Medicine 200-day simple moving average is 4.58, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
22
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
108.1M
Price in USD:
1.31
Share Volume:
4.2M
Editas Medicine 52-Week Range
52-Week High:
11.58
52-Week Low:
1.28
Sell
22
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.31 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.31 while EDIT 8-day exponential moving average is 1.53, which is a Sell signal.
-
The stock price of EDIT is 1.31 while Editas Medicine 20-day EMA is 1.88, which makes it a Sell.
-
Editas Medicine 50-day exponential moving average is 2.47 while EDIT share price is 1.31, making it a Sell technically.
-
EDIT stock price is 1.31 and Editas Medicine 200-day simple moving average is 4.44, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Editas Medicine is a Sell
-
Editas Medicine Relative Strength Index (RSI) is 23.89, which suggest Editas Medicine is oversold
-
The Bollinger Bands (25) for Editas Medicine is (1.63 - 2.43), which suggest Editas Medicine is a Sell
-
The Bollinger Bands (100) for Editas Medicine is (2.37 - 4.05), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.